Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Accounts Payable & Accrued Expense : ¥1,201 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Jincheng Pharmaceutical Group Co Accounts Payable & Accrued Expense?

Shandong Jincheng Pharmaceutical Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥1,269 Mil) to Dec. 2023 (¥1,358 Mil) but then declined from Dec. 2023 (¥1,358 Mil) to Mar. 2024 (¥1,201 Mil).

Shandong Jincheng Pharmaceutical Group Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥976 Mil) to Dec. 2022 (¥1,275 Mil) and increased from Dec. 2022 (¥1,275 Mil) to Dec. 2023 (¥1,358 Mil).

Shandong Jincheng Pharmaceutical Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shandong Jincheng Pharmaceutical Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Jincheng Pharmaceutical Group Co Accounts Payable & Accrued Expense Chart

Shandong Jincheng Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

725.17

777.74

975.73

1,275.31

1,358.33

Shandong Jincheng Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1,182.67	1,211.51	1,268.93	1,358.33	1,201.46

Shandong Jincheng Pharmaceutical Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Shandong Jincheng Pharmaceutical Group Co Ltd (SZSE:300233) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No. 1 Shuangshan Road, Zichuan Economic Development Zone, Shandong, Zibo, CHN, 255100

Website

http://www.jinchengpharm.com

Shandong Jincheng Pharmaceutical Group Co Ltd is engaged in the research and development, production and sale of III and IV cephalosporin intermediates and biopharmaceuticals. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company distributes its products within domestic market and to overseas markets.

Executives

Yang Xiu Liang	Executives
Zhang Xue Bo	Director
Zheng Geng Xiu	Director
Zhao Ye Qing	Director
Sun Rui Mei	Executives
Cui Xi Li	Executives
Zhao Hong Fu	Director
Fu Miao Qing	Executives
Zhu Xiao Gang	Directors, executives
Li Jia Quan	Directors, executives
Guo Fang Shui	Supervisors
Chou Qiang	Securities Affairs Representative

Shandong Jincheng Pharmaceutical Group Co (SZSE:300233) Headlines

No Headlines